Postpartum GLP-1 initiation rose 24-fold among commercially insured U.S. women from 2018 to 2025
A JAMA observational study of commercial claims shows sharp increases in postpartum GLP-1 starts, concentrated among women with diabetes and obesity. The trend highlights gaps in breastfeeding safety data and Medicaid coverage. Further studies must address equity and infant outcomes before widespread adoption.
Next steps require observational breastfeeding cohorts and Medicaid claims analyses to assess equity. Regulators and professional societies should issue explicit timing guidance for postpartum resumption, given the 24-fold rise and potential for off-label initiation without documented metabolic diagnoses in 21% of recent cases.
VITALIS: By Q4 2027, postpartum GLP-1 initiation will exceed 4% overall in commercial claims data absent new breastfeeding safety signals.
Sources (3)
- [1]Primary Source(https://jamanetwork.com/journals/jama/article-10.1001/jama.2026.16841)
- [2]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.04217)
- [3]Supporting Source(https://www.nejm.org/doi/full/10.1056/NEJMoa2307563)